Published in Cancer Res on October 01, 1978
Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions. Br J Cancer (1980) 1.52
Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res (2009) 1.46
A comparison of human tumour-cell clonogenicity in methylcellulose and agar culture. Br J Cancer (1980) 1.30
A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. Br J Cancer (1984) 1.25
Measurement of self-renewal in culture of clonogenic cells from human ovarian carcinoma. Br J Cancer (1981) 1.10
Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas. Br J Cancer (1981) 1.10
Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br J Cancer (1982) 1.10
Direct "wet" staining of tumour or haematopoietic colonies in agar culture. Br J Cancer (1979) 0.89
Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay. Br J Cancer (1984) 0.88
Percoll density gradient separation of cells from human malignant effusions. Br J Cancer (1985) 0.87
Density/volume analysis in the study of cellular heterogeneity in human ovarian carcinoma. Br J Cancer (1982) 0.87
cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment. Br J Cancer (1987) 0.86
Human tumour clonogenicity in agar is improved by cell-free ascites. Br J Cancer (1983) 0.84
Human tumour karyology: marked analytic improvement by short-term agar culture. Br J Cancer (1980) 0.82
Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients. J Clin Pathol (1981) 0.82
Modulation of tumour colony growth by irradiated accessory cells. Br J Cancer (1983) 0.82
Advantage of reduced oxygen tension in growth of human melanomas in semi-solid cultures: quantitative analysis. Br J Cancer (1983) 0.80
Comparative analysis of paired- and homeodomain-specific roles in PAX3-FKHR oncogenesis. Int J Clin Exp Pathol (2008) 0.79
Rapid fluorometric detection of drug resistant tumour cells. Br J Cancer (1985) 0.77
The British Association for Cancer Research, 23rd annual general meeting. Edinburgh 29--31 March 1982. Abstracts. Br J Cancer (1982) 0.75
Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits. Am J Pathol (1987) 0.75
Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy. Gut (1985) 0.75
A comparison of two in vitro assays of cell response following in vitro drug and radiation exposures of human tumour xenograft cells. Br J Cancer (1985) 0.75
Analysis of the influence of tumour cell kinetics and host cells on cloning of human malignant effusions in semi-solid agar. Br J Cancer (1985) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med (2001) 11.73
Expression profiling using cDNA microarrays. Nat Genet (1999) 11.58
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer (1975) 10.04
Primary bioassay of human tumor stem cells. Science (1977) 9.69
Data management and analysis for gene expression arrays. Nat Genet (1998) 8.60
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05
A new type of synthetic peptide library for identifying ligand-binding activity. Nature (1991) 7.81
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol (2000) 6.06
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med (1978) 5.78
High speed scintillation autoradiography. Science (1975) 5.15
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res (2001) 4.51
Identification of an amplified, highly expressed gene in a human glioma. Science (1987) 4.21
KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst (1996) 4.16
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A (1998) 3.35
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies. Nat Genet (2001) 3.20
Elevating clinical licensing examinations to professional testing standards. N Y State Dent J (1998) 3.20
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med (1974) 2.97
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia (1989) 2.90
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol (1989) 2.89
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene (2007) 2.83
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci U S A (1999) 2.77
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA (1997) 2.73
Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily. DNA (1987) 2.67
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. Proc Natl Acad Sci U S A (1999) 2.53
Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res (1985) 2.50
Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene (1997) 2.35
Primary bioassay of human myeloma stem cells. J Clin Invest (1977) 2.25
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study. Blood (1990) 2.24
Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J Clin Invest (1970) 2.21
Colon cancer reduction. Questions about implementation of proven techniques. Arch Intern Med (1997) 2.12
B-cell neoplasia in man. Lancet (1974) 2.11
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet (1994) 2.09
Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci U S A (1982) 2.08
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A (1993) 2.08
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst (1994) 2.05
Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res (1997) 1.96
Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med (1979) 1.94
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res (1995) 1.94
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem (1999) 1.92
Occurrence of fragmented 16S rRNA in an obligate bacterial endosymbiont of Paramecium caudatum. Proc Natl Acad Sci U S A (1993) 1.92
Multivariate measurement of gene expression relationships. Genomics (2000) 1.88
Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology (2001) 1.88
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87
UGA is translated as cysteine in pheromone 3 of Euplotes octocarinatus. Proc Natl Acad Sci U S A (1991) 1.77
Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res (1986) 1.75
"Sandwich" solid phase radioimmunoassay for the quantitative deterimination of human immunoglobulins. J Immunol (1969) 1.74
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol (2001) 1.72
Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N Engl J Med (1990) 1.72
Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. Cancer Genet Cytogenet (1999) 1.71
Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br J Cancer (2000) 1.66
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol (1991) 1.64
Expression profiling in cancer using cDNA microarrays. Electrophoresis (1999) 1.58
Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation. J Cell Physiol (2001) 1.58
Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. J Clin Oncol (1996) 1.57
DNA microarray technology: the anticipated impact on the study of human disease. Biochim Biophys Acta (1999) 1.54
Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat (1987) 1.54
Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions. Br J Cancer (1980) 1.52
Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res (1977) 1.52
Dose response evaluation of adriamycin in human neoplasia. Cancer (1977) 1.51
Preparation of permanent slides of intact soft-agar colony cultures of hematopoietic and tumor stem cells. Cancer Res (1979) 1.51
Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res (1991) 1.50
Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs (1996) 1.49
General nonlinear framework for the analysis of gene interaction via multivariate expression arrays. J Biomed Opt (2000) 1.49
Analogues of amonafide and azonafide with novel ring systems. J Med Chem (2000) 1.47
Learning primary care in medical school: does specialty or geographic location of the teaching site make a difference? Am J Med (1999) 1.46
Localization of a gene for Duane retraction syndrome to chromosome 2q31. Am J Hum Genet (1999) 1.46
Effect of beta-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr (1991) 1.45
Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines. J Cell Physiol (2000) 1.45
Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci U S A (1995) 1.44
Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res (1988) 1.43
Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev (1999) 1.42
Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect. N Engl J Med (1970) 1.41
Cecal vitamin bezoar formation inducing abdominal discomfort. Ann Pharmacother (1992) 1.40
Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study. Blood (1991) 1.40
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am J Hum Genet (2001) 1.40
Immunology of the lower respiratory tract. II. The plaque-forming response of canine lymphoid tissues to sheep erythrocytes after intrapulmonary or intravenous immunization. J Clin Invest (1974) 1.39
Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer (1975) 1.39
Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer (2000) 1.39
AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proc Natl Acad Sci U S A (1997) 1.38
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
Kinetics of tumor growth and regression in IgG multiple myeloma. J Clin Invest (1972) 1.38
Sustained elevation of platelet counts by long-term azidothymidine treatment of immunosuppressed mice. J Lab Clin Med (1993) 1.38
Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res (1983) 1.37
Rapid generation of region specific probes by chromosome microdissection and their application. Nat Genet (1992) 1.35
Approach to genotyping errors caused by nontemplated nucleotide addition by Taq DNA polymerase. Genome Res (1995) 1.33
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet (2001) 1.32